Drug Topics E-News:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Unsubscribe from this list.
Drug Topics E-News
July 20, 2010
TOP SEARCHES: Supplements // FDA approvals // E-prescribing
In this issue
FDA tackles drug labeling
Rosiglitazone stays on market
No shortage of children¹s meds
Controlled substance use
Medicare covers vaccine
Diabetes-testing supplies
Low back pain guidelines
Endometriosis recommendations
Statin use lowers after GBS
Coumadin recalled
OTC use neglected
Supplements do not benefit MI
NCPA receives grant
Sandoz wins DIANA award
Phil Hagerman receives award
 


Survey

Have you ever volunteered your professional services, either at home or abroad?

Yes
 
68%
No   32%
Total Votes:   147

This month we would like to know...

How do you deal with the physically stressful side of work in the pharmacy (e.g., being on your feet for 12 hours a day, cradling the telephone handset between your shoulder and neck, etc.)?

• I receive chiropractic/ massotherapy/ acupuncture/ etc. as needed
• I am receiving physical therapy
• I have had some form of surgery
• I have no physical problems connected with work
• Denial is working well for me

Click here to vote


Contact Us
Click here to contact a Drug Topics editor.

Click here to contact a Drug Topics sales representative.

Click here to learn about direct mail, reprints and classifieds in Drug Topics.

Drug Topics Digital Edition

Click here to view the current edition.

Click here to subscribe.

 

Government agency news

Planned FDA guidance on drug labeling seeks to help reduce medication errors
FDA is once again tackling the naming, labeling, and packaging practices connected with drugs and biologics, according to a top official. More...

FDA panel votes to keep rosiglitazone on market, but wants label changes
An FDA advisory panel voted 20 to 12 to recommend that the agency allow rosiglitazone (Avandia, GlaxoSmithKline) to remain on the market. However, most panelists want to see tougher warnings on the diabetes drug’s label, according to various media reports. More...
FDA: No shortage of children’s medications; Johnson and Johnson widens recall
FDA said on June 25 that it does not expect any shortage of children’s pain and allergy medications, despite Johnson & Johnson’s inability to resume production until at least next year, Reuters reported. The company produces an estimated 70% of liquid over-the-counter medications for children. More...
DEA seeks comments on dispensing controlled drugs to LTC residents
The Drug Enforcement Administration (DEA) has issued a notice in the Federal Register requesting input about the dispensing of controlled substances for residents in long-term-care (LTC) facilities. More...

Clinical news

Fluzone High-Dose vaccine covered under Medicare Part B
Written confirmation is now available from the Centers for Medicare and Medicaid Services indicating that Fluzone High-Dose (Sanofi Pasteur) influenza virus vaccine for patients 65 years or older is a benefit covered by Medicare Part B and will be reimbursed for the upcoming 2010–11 influenza season. More...
CMS favors continued local pharmacy distribution of diabetes-testing supplies to seniors
The Centers for Medicare & Medicaid Services (CMS) issued a proposed regulation on June 25 that would exempt community pharmacies from the upcoming bidding process for Medicare Part B diabetes-testing supplies, along with instructions that exempt most independent community pharmacies from accreditation requirements. More...
Recent low back pain guidelines offer similar advice
Recent clinical practice guidelines offer similar recommendations for assessing and managing low back pain, and clinicians can improve patient care by adopting these recommendations, according to a review published in the June issue of The Spine Journal, reported HealthDay News. More...
Updated recommendations for endometriosis released
Women who suffer from endometriosis-related pain should be treated first with conservative, nonsurgical approaches and then with more invasive options if pain does not resolve, and with hysterectomy only as a last resort, according to a practice bulletin issued by the American College of Obstetricians and Gynecologists and published in the July issue of Obstetrics & Gynecology, reported HealthDay News. More...
Statin use lowers after gastric bypass surgery
Long-term data from a retrospective cohort study showed that hyperlipidemic obese patients had more than a 90% reduction in their need of lipid-lowering therapy following laparoscopic gastric-bypass surgery, MedPage Today reported. More...

Medication safety

Coumadin 1-mg tablet blister packs recalled
A recall of 3 lots of physician sample blister packs of Coumadin 1-mg tablets and 5 lots of Coumadin 1-mg tablet hospital unit dose blister packs has been initiated by Bristol-Myers Squibb. More...

Cardiology clinicians neglect to determine patient use of nutraceuticals and OTC agents
The use of nutraceuticals and nonprescription over-the-counter (OTC) drugs may be high; however, the use of these agents may largely be ignored by cardiovascular clinicians, according to research published in the July 6 issue of the Annals of Internal Medicine. More...

Folic acid, vitamin B12 do not reduce vascular events
Supplementation with folic acid and vitamin B12 over an extended period does not have a beneficial effect on vascular outcomes in individuals who have had a myocardial infarction, but it also poses no excess cancer risk, according to a study in the June 23/30 issue of the Journal of the American Medical Association, HealthDay News reported. More...

Awards

NCPA Foundation receives $100,000 for Catalyst Grant Award
Purdue Pharma has awarded the National Community Pharmacists Association (NCPA) Foundation a $100,000 grant to advance its efforts to stimulate community-pharmacy-based research that helps improve patient care and education. More...
Sandoz wins prestigious DIANA award for tacrolimus launch
The Healthcare Distribution Management Association has recognized Sandoz Inc. with a 2010 Distribution Industry Award for Notable Achievements in Healthcare (DIANA) in the Best New Generic Product Introduction Award category. More...
Phil Hagerman receives prestigious Ernst & Young award
Phil Hagerman, RPh, president and CEO of Diplomat Specialty Pharmacy, was named Ernst & Young Entrepreneur of the Year for the Michigan and Northwest Ohio region. He was honored June 10 at an awards ceremony in Dearborn, Mich. More...

Meeting

August 28–31 NACDS Pharmacy & Technology Conference
San Diego, CA
Contact:
413 North Lee Street
Alexandria, VA 22314
703-549-3001

 
 

 You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone
numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other
opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or
fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar
Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.